Lucia Gabriele Selected Research

Lucia Gabriele Research Topics

Disease

24	Neoplasms (Cancer) 01/2021 - 02/2011
9	Melanoma (Melanoma, Malignant) 01/2022 - 12/2012
3	COVID-19 02/2022 - 01/2021
3	Neoplasm Metastasis (Metastasis) 04/2016 - 12/2012
2	Tuberculosis (Tuberculoses) 01/2019 - 01/2013
2	Breast Neoplasms (Breast Cancer) 01/2019 - 09/2012
1	Glioblastoma (Glioblastoma Multiforme) 04/2022
1	Inflammation (Inflammations) 02/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Rheumatoid Arthritis 01/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2016
1	Hypersensitivity (Allergy) 09/2013
1	Experimental Melanoma 01/2013
1	Granuloma 01/2013
1	Infections 01/2013
1	Contact Dermatitis (Eczema, Contact) 03/2004

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 11/2019 - 01/2016
5	interferon regulatory factor-8 (interferon consensus sequence binding protein)IBA 10/2014 - 12/2012
5	AntigensIBA 12/2013 - 03/2004
4	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2017
3	Interferon Type IIBA 12/2019 - 02/2011
3	Transcription Factors (Transcription Factor)IBA 10/2014 - 01/2013
2	AntibodiesIBA 01/2022 - 01/2021
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022 - 01/2017
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2022 - 01/2017
2	Neutralizing AntibodiesIBA 01/2022 - 01/2021
2	Biological ProductsIBA 01/2021 - 04/2016
2	Neoplasm Antigens (Tumor Antigens)IBA 10/2020 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2019 - 04/2016
2	Estrogen ReceptorsIBA 01/2019 - 01/2018
2	VaccinesIBA 01/2019 - 10/2014
2	Interferon Regulatory FactorsIBA 10/2014 - 01/2013
2	ChemokinesIBA 01/2013 - 12/2012
1	epidermal growth factor receptor VIIIIBA 04/2022
1	ErbB Receptors (EGF Receptor)IBA 04/2022
1	Interferon LambdaIBA 02/2022
1	C-Reactive ProteinIBA 02/2022
1	AlbuminsIBA 02/2022
1	fibrin fragment D (D-dimer)IBA 02/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2022
1	LigandsIBA 01/2022
1	cirazolineIBA 01/2022
1	CatecholaminesIBA 01/2022
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2022
1	Immune Checkpoint ProteinsIBA 10/2020
1	Immunomodulating AgentsIBA 10/2020
1	Chimeric Antigen ReceptorsIBA 01/2020
1	CytokinesIBA 11/2019
1	Interleukin-6 (Interleukin 6)IBA 11/2019
1	Interleukin-8 (Interleukin 8)IBA 11/2019
1	Granzymes (Granzyme)IBA 10/2019
1	NivolumabIBA 10/2019
1	Tamoxifen FDA LinkGeneric 01/2019
1	AutoantibodiesIBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	Silybin (Lagosa)IBA 01/2018
1	Estrogens (Estrogen)FDA Link 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Histones (Histone)IBA 01/2017
1	Azacitidine (5 Azacytidine)FDA Link 01/2017
1	Propranolol (Inderal)FDA LinkGeneric 01/2017
1	romidepsin (FK228)FDA Link 01/2017
1	Drug CombinationsIBA 01/2017
1	Histone Deacetylase InhibitorsIBA 05/2016
1	MethyltransferasesIBA 05/2016
1	DNA (Deoxyribonucleic Acid)IBA 05/2016
1	Liposomes (Liposome)IBA 04/2016
1	Peptides (Polypeptides)IBA 04/2016
1	Chemokine CXCL12IBA 04/2016
1	Antineoplastic Agents (Antineoplastics)IBA 01/2016
1	Antimalarials (Antimalarial Agents)IBA 01/2016
1	Pyrimethamine (Daraprim)FDA Link 01/2016
1	methylbenzoprimIBA 01/2016
1	Histocompatibility Antigens Class IIBA 12/2013
1	Interleukin-33IBA 09/2013
1	AllergensIBA 09/2013
1	Chemokine ReceptorsIBA 12/2012
1	Interleukin-27 (Interleukin 27)IBA 12/2012
1	Decitabine FDA Link 12/2012
1	Cytotoxins (Cytolysins)IBA 09/2012
1	Proteins (Proteins, Gene)FDA Link 09/2012
1	apicidinIBA 09/2012
1	HMGB1 Protein (HMG1)IBA 09/2012
1	Docetaxel (Taxotere)FDA Link 09/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2011

Therapy/Procedure

6	Immunotherapy 01/2021 - 01/2017
6	Therapeutics 10/2020 - 04/2016
1	Lab-On-A-Chip Devices 01/2021
1	Heterologous Transplantation (Xenotransplantation) 01/2016
1	Drug Therapy (Chemotherapy) 02/2011